
Opinion|Videos|March 20, 2025
Clinical Perspectives on Early Use of RAD-ENZ
Panelists discuss how early implementation of RAD-ENZ combination therapy requires careful consideration of patient characteristics, disease burden, and long-term treatment planning while potentially offering the greatest benefit when initiated before significant disease progression occurs.
Advertisement
Video Player is loading.
Episodes in this series

Video content above is prompted by the following:
- What are your clinical perspectives on using this combination therapy upfront and early in the disease stage?
- How can the findings from PEACE-3 influence the design of future trials, particularly with respect to patient selection, end points, and safety monitoring?
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Trial launches of neuromodulation therapy for erectile dysfunction after radical prostatectomy
2
Andrea B. Apolo, MD, discusses survival gains with EV/pembrolizumab in bladder cancer
3
Rectal diazepam eases instillation of nadofaragene firadenovec in NMIBC
4
PROSTOX ultra launches on US market following new data presented at ASTRO 2025
5